Testing effectiveness (Phase 2)Study completedNCT00005855
What this trial is testing
Efaproxiral Plus Carmustine in Treating Patients With Progressive or Recurrent Malignant Glioma
Who this might be right for
Brain and Central Nervous System Tumors
New Approaches to Brain Tumor Therapy Consortium 48